Coinbase Surges on Trump's CLARITY Act Endorsement, but Fundamentals Remain Fragile

What happened

Coinbase shares jumped 8% premarket on August 20, 2026, after President Trump met with crypto executives including CEO Brian Armstrong and called on Congress to pass the CLARITY Act, which aims to provide clearer regulatory boundaries for digital assets. The rally also benefited from a sharp rebound in cryptocurrency prices, offering temporary relief to a stock down 29% over the past year. However, the latest DeepValue master report maintains a 'POTENTIAL SELL' rating with conviction 4.0, citing Q1 2026 net loss of $394 million on net revenue of $1.339 billion and a 50% year-over-year decline in trading volume. The report highlights that the derivatives revenue uplift was 'due mainly' to the acquired Deribit venue rather than organic growth, and that the company's forward returns depend on Q2 2026 proving GAAP profitability improvement and accelerated regulatory approvals. While the CLARITY Act endorsement is a positive policy signal, the master report notes that the bill previously faced delays and Coinbase itself opposed an earlier version, leaving execution risk on the regulatory front.

Implication

Investors should treat the 8% jump as a sentiment-driven bounce within a broader downtrend, as the master report's base case implies $185 with a bear case of $140, suggesting limited upside from current levels. The news does not change the core thesis: Coinbase needs to demonstrate that its restructuring plan lowers operating expenses and narrows GAAP losses in Q2 2026, and that U.S. regulated perpetual futures gain traction beyond the Deribit acquisition. The CLARITY Act endorsement could accelerate regulatory clarity, but the report notes that CFTC case-by-case review remains a bottleneck, and the bill's passage is not guaranteed given past objections. Until there is concrete evidence of improved financials and organic derivatives scaling, the stock's 62.5x P/E and 26.5x EV/EBITDA multiples appear to price in a recovery that is not yet supported by fundamentals. Long-term investors may find better entry points near $150, while short-term traders should be wary of fading the rally if volumes fail to sustain.

Thesis delta

The positive regulatory headline does not materially alter the bearish thesis from the master report, which already accounted for legislative tailwinds but stressed execution risk. The core concern remains the company's reliance on acquisition-driven derivatives growth and the need for Q2 2026 to show a genuine cost reset and net income improvement. If the CLARITY Act accelerates CFTC approvals, it could increase the probability of the bull scenario ($240), but that is contingent on legislative passage and operational follow-through, which are not yet proven.